Register
Login:
Share:
Email Facebook Twitter

Michael Masterman introduces Saffron Energy to London AIM Market (LON: SRON) Watch here

Michael Masterman introduces Saffron Energy to London AIM Market (LON: SRON)


Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 59.50Bid: 59.00Ask: 60.00Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 1.00Spread as %: 1.69%Open: 57.75High: 60.00Low: 57.75Yesterday’s Close: 59.50

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
59.50

Share Price SpacerBid
59.00

Share Price SpacerAsk
60.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
285,094

Share Price SpacerOpen
57.75

Share Price SpacerHigh
60.00

Share Price SpacerLow
57.75

Share Price SpacerClose
59.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 124.64m £74.16m 10,000

52 Week High 69.00 52 Week High Date 17-FEB-2017
52 Week Low 24.50 52 Week Low Date 20-APR-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
30 146,936 125,371 -13.523 -4.40 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Feb-17
11:11:57
52.00
538,462
Sell* 
59.00
60.00
280.00k
Trade Type:
Ordinary

27-Feb-17
16:25:15
59.0505
10,000
Sell* 
59.00
60.00
5,905
Trade Type:
Ordinary

27-Feb-17
16:16:42
59.50
5,000
 
59.00
60.00
2,975
Trade Type:
Ordinary




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Mon 23:09seagulAll looking good59.50No Opinion
People will wake up to this
Mon 17:17leasspread59.50No Opinion
very tight (ohhhhhhh matron) Trades showing as sells but suspect most of them are actually buys. Looking good for the next step up.
Sat 22:25Cammy123Awareness59.00No Opinion
Going by amount of buys people seem to be more aware of IMM but,still nowhere near where it should be regarding share price anyway ,back to my drink.
Fri 13:47oilbaggersmall spread58.00Strong Buy
smallest spread that I have seen for Immupharma - 58.65p to buy and 58.55p to sell.
It makes it hard to distinguish buys and sells today but to me the majority look like buys so not sure why MM moved the buy from 59p to 58.65p over the last hour.
Fri 10:48panicattackBounce56.00Strong Buy
Nice to see the bounce today, and hopefully resumption of uptrend.
Thu 13:53hunkymonkeyOne to keep track on...55.25No Opinion

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.